Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast Enhanced Ultrasound and Elastography of the Neonatal Brain
2024-519611-33-00Phase 4Authorised
- Sponsor
- Varsinais-Suomen hyvinvointialue
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sulfur hexafluoride (5 arms), sponsored by Varsinais-Suomen hyvinvointialue. Primary endpoint: Target enrollment of neonatal cohorts. Planned start Dec 2024; status: authorised.
02
Drugs
sulfur hexafluoride
Beyond the preview
Go deeper on 2024-519611-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519611-33-00.